2020 Annual Meeting of INFORM has gone Virtual!
October 27th – 28th
Virtual Registration Coming Soon!
Please continue to prepare your abstracts and submit them by September 1, 2020.
https://informnetwork.org/call-for-abstracts/
Ultragenyx Announces U.S. FDA Approval of Dojolvi™ (UX007/triheptanoin),
the First FDA-Approved Therapy
for the Treatment of Long-chain Fatty Acid Oxidation Disorders
the First FDA-Approved Therapy
for the Treatment of Long-chain Fatty Acid Oxidation Disorders
INFORM Network
The International Network for Fatty Acid Oxidation Research and Management (INFORM) was formed by Jerry Vockley in order to promote research and discussion into the cause, diagnosis, and management of fatty acid oxidation disorders (FAODs). We offer several learning opportunities throughout the year for patients, families, and researchers. Our network will provide a collaborative framework for ongoing communication and research regarding these disorders, as well as work with our partners to sponsor a symposium each year. Please plan to join us in the future to hear from the experts on a wide range of topics from molecular pathophysiology to treatment strategies.
Abstracts
We believe in the power of fatty acid oxidation research to gain a better understanding of these disorders. You can review abstracts from INFORM Network’s previous international symposiums or submit an abstract for our 2020 conference in Freiburg, Germany.
Virtual Tissue Bank
The Virtual Tissue Bank (VTB) grew out of the desire to share research sample information and testing results to help advance the diagnosis and treatment of fatty oxidation disorders and the carnitine cycle in order to increase knowledge and help patients worldwide.
INFORM Families
At INFORM Network, we offer a comprehensive resource for families and friends impacted by fatty acid oxidation disorders. Here you can learn the latest developments in genetic research and access important information on screening, diagnosis, and treatment.
Sponsor INFORM 2020 Conference
Our 2020 FAOD conference and symposium in Freiburg, Germany will discuss the proper diagnostic interpretation of laboratory testing, the development of new therapeutic strategies, and the role of newborn screening in preventing complications. It will also serve as our annual meeting.
Check Back Soon for Upcoming
Research Webinars
Watch Previous Webinars Below
(To view presentations, click image below)
4/13/2020
Assessment of the Efficacy of Medium/Branched Chain Fatty Acids in Treating FAODs using Patient Fibroblasts
4/7/2020
Mito Matters Q&A with Dr. Jerry Vockley, MD, PhD
Join us for a Q & A with Dr. Jerry Vockley (UPMC, INFORM) to discuss the impact of Covid-19 for Fatty Acid Oxidation Disorders.
12/16/2019
Emerging Therapies for Phenylketonuria
Join Jerry Vockley, MD, PhD, director of the Center for Rare Disease Therapy and chief, Medical Genetics, at UPMC Children’s Hospital of Pittsburgh for a free webinar. Dr. Vockley will discuss emerging therapies for PKU or phenylketonuria, an inborn error of protein metabolism. The presentation is designed for patients, parents, guardians, and caregivers and will be followed by a live question and answer session.
10/4/2019
Monthly Mito: Expert Series
Dr. Jerry Vockey, MD, PhD, University of Pittsburgh Children’s Hospital,
International Network for Fatty Acid Oxidation Research and Management (INFORM)
6/17/2019
The Fate of Medium-Chain Fatty Acids in Very Long-Chain Acyl-CoA Dehydrogenase Deficient (VCLADD): A Matter of Sex?
Zeinab Wehbe, PhD Student, Department of General Pediatrics and Adolescent Medicine
Laboratory of Clinical Biochemistry and Metabolism
Medical Center – University of Freiburg
Faculty of Medicine, University of Freiburg
2/5/2019
Novel Therapies for Fatty Acid Oxidation Disorders
by Jerry Vockley, MD, PhD
5/21/2018
Enhancing Expression and Chaperoning Unstable Proteins:
Getting closer to effective therapy for fatty acid b-oxidation disorders
Al-Walid Mohsen, PhD Research Associate Professor of Pediatrics Medical Genetics,
Children’s Hospital of Pittsburgh / University of Pittsburgh.
4/23/2018
Loss of Retinal Pigment Epithelium: The Initial Event in LCHAD Retinopathy Progression?
Melanie Gillingham, PhD, RD / Associate Professor /Department of Molecular and Medical Genetics
Graduate Programs in Human Nutrition / Oregon Health & Science University
Modeling LCHAD Retinopathy in a Patient Derived Retinal Pigment Epithelium
Tiffany DeVine, PhD / Postdoctoral researcher /Department of
Molecular and Medical Genetics
Oregon Health & Science University
Approximately
“I appreciate that INFORM always provides us the most advanced, the most professional, and the most comprehensive information about defects of beta-oxidation.”
“Together we can generate the energy to beat these diseases”
“INFORM brings together the best and brightest researchers and physicians from around the world to discuss cutting edge research and best and new practices in fatty acid oxidation disorders.”
“The challenge with being on the cutting edge is that you are always dealing with things that didn’t happen yesterday”.
2020 Sponsors
Special thanks to our 2020 Sponsors!
With significant new research and best practices on the horizon,
INFORM 2020 promises to be our most informative symposium ever!
Taking place October 27-28, 2020 in Freiburg, Germany.
Unlocking the Future
We are committed to discovering new FAOD treatments and cures to improve the lives of our patients and their families.
